| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $453.2M | -2.3% | +2.0% |
| Cost of Revenue | $302.9M | -3.0% | +3.0% |
| Gross Profit | $150.3M | -0.9% | +0.0% |
| R&D Expense | $19.5M | -1.5% | +4.8% |
| SG&A Expense | $71.5M | +1.8% | -2.4% |
| Operating Income | $53.2M | -9.5% | -5.3% |
| Pre-tax Income | $49.2M | +2.4% | +2.6% |
| Income Tax | $9.0M | -4.0% | +31.3% |
| Net Income | $40.2M | +3.9% | -2.2% |
| EPS (Basic) | $2.44 | +5.6% | -0.4% |
| EPS (Diluted) | $2.33 | +5.0% | -2.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $345.2M | +2.5% | +260.3% |
| Accounts Receivable | $870.5M | +4.5% | +29.5% |
| Inventory | $435.3M | -3.8% | -0.8% |
| Current Assets | $1.72B | +1.8% | +35.0% |
| Total Assets | $2.55B | +1.3% | +22.8% |
| Current Liabilities | $529.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $93.8M | — | — |
| Capital Expenditures | $21.3M | — | — |
| Investing Cash Flow | -$28.5M | — | — |
| Financing Cash Flow | $174.1M | — | — |
| Free Cash Flow | $72.5M | — | — |
| -12.4% |
| Long-term Debt | $1.00B | -0.1% | +111.9% |
| Total Liabilities | $1.66B | -1.0% | +38.2% |
| Stockholders' Equity | $894.3M | +5.8% | +1.7% |